Skip to content
  • Home
  • Stocks
    • Large-Cap
    • S&P 500
    • Mid-Cap
    • Small-Cap
    • Foreign
    • micro cap stocks
    • Industries
    • IPOs
  • Crypto
    • Bitcoin Hub
    • Ethereum Hub
    • Comparisons
    • Safety
  • ETFs
  • Blog
  • Privacy Policy
  • Home
  • Stocks
    • Large-Cap
    • S&P 500
    • Mid-Cap
    • Small-Cap
    • Foreign
    • micro cap stocks
    • Industries
    • IPOs
  • Crypto
    • Bitcoin Hub
    • Ethereum Hub
    • Comparisons
    • Safety
  • ETFs
  • Blog
  • Privacy Policy

Company Name: Egalet Corporation

Egalet Corporation is a specialty pharmaceutical company. The company is engaged in the development, manufacturing and commercialization of pain treatments. The company markets approved pain products and is developing its pipeline of abuse-deterrent product candidates using its proprietary Guardian Technology.

Ticker Symbol: EGLT (NASDAQ)

Company Website: http://egalet.com

Social Media:

Egalet LinkedIn

Egalet Corporation Twitter

Egalet Corporation YouTube

Headquarters: Wayne, PA

 

Publicly Traded Companies by Sector and Industry

List of Publicly Traded Banks

List of Publicly Traded Large-Cap Bank Stocks

List of Publicly Traded Mid-Cap Bank Stocks

List of Publicly Traded Small-Cap Bank Stocks

List of Publicly Traded Micro-Cap Bank Stocks

List of Publicly Traded Large-Cap Insurance Stocks

List of Publicly Traded Mid-Cap Insurance Stocks

List of Publicly Traded Small-Cap Insurance Stocks
List of Publicly Traded Micro-Cap Insurance Stocks
 

List of Large-Cap Financial Sector Stocks

List of Mid-Cap Financial Sector Stocks

List of Small-Cap Financial Sector Stocks

List of Micro-Cap Financial Sector Stocks

Providing data-driven insights for smart investing in public markets, crypto, and ETFs.

Facebook Twitter Youtube Linkedin

Quick Links

Stocks

Crypto

ETFs

Tools

Quick Links

Learn

News & Insights

About Us

Contact

Partners

Quick Links

Privacy Policy

Terms of Service

Disclaimer

Disclosures

Data Sources

Informational only, not financial advice.

© 2025 InvestSnips. All rights reserved